3,4,6-trihydroxy-8-(hydroxymethyl)-2-methoxy-5H-benzo[7]annulen-5-one | 1164446-84-7

• 分子结构分类: 有机化合物 - 碳氢化合物衍生物 - 环庚三烯酮
• 英文名称: 3,4,6-trihydroxy-8-(hydroxymethyl)-2-methoxy-5H-benzo[7]annulen-5-one
• 英文别名: 3,4,6-Trihydroxy-8-(hydroxymethyl)-2-methoxybenzo[7]annulen-5-one；3,4,6-trihydroxy-8-(hydroxymethyl)-2-methoxybenzo[7]annulen-5-one
• CAS: 1164446-84-7
• 化学式: C₁₃H₁₂O₆
• 分子量: 264.235
• InChiKey: YBKGUAGUNGRAGO-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.5
• 重原子数：
  19
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.15
• 拓扑面积：
  107
• 氢给体数：
  4
• 氢受体数：
  6

反应信息

• 作为产物：
  描述：

  3-甲氧基儿茶酚 、 5-(hydroxymethyl)benzene-1,2,3-triol 在 双氧水 、 horseradish peroxidase 作用下， 以 aq. phosphate buffer 、 丙酮 为溶剂， 以52%的产率得到3,4,6-trihydroxy-8-(hydroxymethyl)-2-methoxy-5H-benzo[7]annulen-5-one
  参考文献：
  名称：

  发现 TLR1/TLR2 复合物的小分子抑制剂

  摘要：

  作为先天免疫的重要调节剂， Toll 样受体 1 和 2 (TLR1/TLR2) 的蛋白质复合物为治疗各种免疫疾病提供了一个有吸引力的靶点。新型化合物 CU-CPT22 可以与特异性脂蛋白配体竞争结合 TLR1/TLR2（见图），具有高抑制活性和特异性。还观察到来自 TNF-α 和 IL-1β 的下游信号受到抑制。

  DOI：

  10.1002/anie.201204910

文献信息

• [EN] ANTAGONISTS OF THE TOLL-LIKE RECEPTOR 1/2 COMPLEX<br/>[FR] ANTAGONISTES DU COMPLEXE DE RÉCEPTEUR 1/2 DE TYPE TOLL
  申请人：UNIV COLORADO REGENTS

  公开号：WO2014022287A1

  公开（公告）日：2014-02-06

  Provided are compounds, compositions and methods for treating Toll-like receptor 1/2 complex (TLRI/2) related inflammatory disorders. Small molecules, based on the benzotropolone scaffold, capable of influencing downstream signaling are dislcosed as well as methods of making and modifying these molecules. Also provided are methods for treating a subject for a clinical condition associated with Toll¬ like receptor complex 1/2 activation, comprising administering to the subject an effective amount of a benzotropolone compound.

  提供了用于治疗Toll样受体1/2复合物（TLR1/2）相关炎症性疾病的化合物、组合物和方法。基于苯并三酮骨架的小分子，能够影响下游信号传导，以及制备和修改这些分子的方法也已披露。还提供了用于治疗与Toll样受体复合物1/2激活相关的临床状况的方法，包括向受试者施用有效量的苯并三酮化合物。
• ANTAGONISTS OF THE TOLL-LIKE RECEPTOR 1/2 COMPLEX
  申请人：THE REGENTS OF THE UNIVERSITY OF COLORADO, a body corporate

  公开号：US20150251987A1

  公开（公告）日：2015-09-10

  Provided are compounds, compositions and methods for treating Toll-like receptor 1/2 complex (TLRI/2) related inflammatory disorders. Small molecules, based on the benzotropolone scaffold, capable of influencing downstream signaling are disclosed as well as methods of making and modifying these molecules. Also provided are methods for treating a subject for a clinical condition associated with Toll-like receptor complex 1/2 activation, comprising administering to the subject an effective amount of a benzotropolone compound.

  提供了用于治疗Toll样受体1/2复合物（TLRI/2）相关炎症性疾病的化合物、组合物和方法。公开了基于苯并三环酮支架的小分子，能够影响下游信号传导，以及制备和修改这些分子的方法。还提供了用于治疗与Toll样受体复合物1/2激活相关的临床状况的方法，包括向受试者施用有效量的苯并三环酮化合物。
• EP2296760B1
  申请人：——

  公开号：EP2296760B1

  公开（公告）日：2016-03-16
• USE OF BENZOTROPOLONE DERIVATIVES AS UV ABSORBERS AND ANTIOXIDANTS AND THEIR USE IN SUNSCREENS AND/OR COSMETIC COMPOSITIONS
  申请人：Wagner Barbara

  公开号：US20110123468A1

  公开（公告）日：2011-05-26

  Described is the use of benzotropolone and their derivatives, especially the compounds of formula (1); wherein R 2 , R 3 , R 4 , R 5 and R 6 independently of one another are hydrogen; OH; C 1 -C 30 alkyl, C 2 -C 30 al-kenyl, C 1 -C 30 alkoxy, C 3 -C 12 cycloalkyl or C 1 C 30 hydroxyalkyl, which may be substituted by one or more E and/or interrupted by one or more D; C 6 -C 20 aryl, which may be substituted by one or more G; C 4 -C 20 heteroaryl, which may be substituted by one or more G, C 2 -C 18 alkenyl, C 2 -C 18 alkynyl, C 7 -C 25 aralkyl, CN, or —CO—R 17 ; C 1 -C 30 mono- or dialkylamino; COR 9 ; COOR 9 ; CONR 9 R 10 ; CN; SO 2 R 9 ; OCOOR 9 ; OCOR 9 ; NHCOOR 9 ; NR 9 COR 10 ; NH 2 ; *—(CO)—NH—(CH 2 ) n1 —(PO)—(OR 11 ) 2 ; —(CO)—O—(CH 2 ) n1 —(PO)—(OR 11 ) 2 ; sulphate; sulphonate; phosphate; phosphonate; —(CH 2 ) n2 —[O—(SO 2 )] n3 —OR 11 ; —O—(CH 2 ) n4 (CO) n5 —R 11 ; —(O) n6 —(CH 2 ) n7 —(PO)—(OR 9 ) 2 ; —(O) n6 —(CH 2 ) n7 —SO 2 —OR 9 ; halogen; organosilanyl; organo-siloxanyl; or a sugar residue linked directly in an α- or β-mode via the anomeric oxygen to the benzotropolone system or via a linear or branched alkylene, alkenylene, alkadiene or alkatriene spacer (sugar-(CH 2 ) n —(X 1 ) 1 or 0 -benzotropolone system, wherein n=1-10 and X 1 =—O—; —(CO)—; —O—CO—; —COO—, —NH—; —S—; —SO 2 —); R 1 , R 7 and R 8 independently of one another are hydrogen; C 1 C 12 alkyl or C 3 -C 12 -cycloalkyl, which may be substituted by one or more E and/or interrupted by one or more D; C 6 -C 20 aryl, which may be substituted by one or more G; C 4 -C 20 heteroaryl, which may be substituted by one or more G, C 2 -C 18 alkenyl, C 2 -C 18 alkynyl, C 7 -C 25 aralkyl, or COOR 9 ; COR 9 ; CONR 9 R 10 ; SO 3 R 9 ; SO 2 R 9 ; PO 3 (R 9 ) 2 ; PO 2 (R 9 ) 2 ; organosilanyl; organosiloxanyl; or a sugar residue linked directly in an α- or β-mode via the anomeric oxygen to the benzotropolone system or via a linear or branched alkylene, alkenylene, alkadiene or alkatriene spacer (sugar-(CH 2 ) n —(X 2 ) 1 or 0 —*, wherein n=1-10 and X 2 =—C(═O)—; —O—CO—*); R 9 and R 10 independently from each other are hydrogen; C 1 C 18 alkyl or C 3 -C 12 -cycloalkyl which may be substituted by one or more E and/or interrupted by one or more D; C 6 -C 20 aryl, which may be substituted by one or more G; C 4 -C 20 heteroaryl, which may be substituted by one or more G; organosilanyl; organosiloxanyl; or a sugar residue linked directly in an α- or β-mode via the anomeric oxygen or via a linear or branched alkylene, alkenylene, alkadiene or alkatriene spacer (sugar-(CH 2 ) n —*, wherein n=1-10); or R 9 and R 10 together form a five or six membered ring, R 11 is hydrogen; or C 1 -C 5 alkyl; n 1 , n 2 , n 4 and n 7 independently from each other are a number from 1 to 5; n 3 , n 5 and n 6 independently from each other are a 0; or 1; D is —CO—; —COO—; —S—; —SO—; —SO2-; —O—; —NR 14 —; —S 1 R 19 R 20 —; —POR 11 —; —CR 12 ═CR 13 —; or —C≡C—; and E is —OR 18 ; —SR 18 ; —NR 14 R 15 ; —NR 14 COR 15 ; —COR 17 ; —COOR 16 ; —CONR 14 R 15 ; —CN; halogen; Or SO 3 R 18 ; SO 2 R 18 ; PO 3 (R 18 ) 2 ; PO 2 (R 18 ) 2 ; organosilanyl; organosiloxanyl; or a sugar residue linked directly in an α- or β-mode via the anomeric oxygen or via a linear or branched alkylene, alkenylene, alkadiene or alkatriene spacer (sugar-(CH 2 )n-(X 1 ) 1 or 0 —*, wherein n=1-10 and X1=—O—; —C(═O)—; —O—CO—; —COO—; —NH—; —S—; —SO 2 —); G is E; C 1 -C 18 alkyl, which is optionally interrupted by D; C 1 -C 18 perfluoroalkyl; C 1 -C 18 alkoxy, which is optionally substituted by E and/or interrupted by D; wherein R 12 , R 13 , R 14 and R 15 independently of each other are hydrogen; C 6 -C 18 aryl which is optionally substituted by OH, C 1 -C 18 alkyl or C 1 -C 18 alkoxy; C 1 -C 18 alkyl, which is optionally interrupted by —O—; or Ri4 and Ri5 together form a five or six membered ring, Ri6 is hydrogen; C6-Ci8aryl which is optionally substituted by OH, C 1 -C 18 alkyl or d-C 18 alkoxy; C 1 -C 18 alkyl which is optionally interrupted by —O—; R 17 is H; C 6 -C 18 aryl which is optionally substituted by OH, C 1 -C 18 alkyl or C 1 -C 18 alkoxy; or d-C 18 alkyl which is optionally interrupted by —O—; R 18 is hydrogen; C 6 -C 18 aryl, which is optionally substituted by OH, C 1 -C 18 alkyl or d-C 18 alkoxy; C 1 -C 18 alkyl, which is optionally interrupted by —O—; R 19 and R 20 independently of each other are hydrogen; C 1 -C 18 alkyl; C 6 -C 18 aryl which is optionally substituted by C 1 -C 18 alkyl; and R 21 is C 1 -C 18 alkyl; or C 6 -C 18 aryl, which is substituted by C 1 -C 18 alkyl; * means, that this radical is directed to the benzotropolone moiety; for the protection of human and animal hair and skin against UV radiation.
• US9517993B2
  申请人：——

  公开号：US9517993B2

  公开（公告）日：2016-12-13